Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5
Bristol-Myers Squibb

Bristol-Myers Squibb (BMY UN)

3
Analysis
Health CareUnited States
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
more
11 Oct 2015 15:13

HILLARY! Scourge of Wall, Savior of Main - Preventer of Market Crashes, and Economic Crises

On October 8th, Hillary Clinton offered an Op-Ed on Bloomberg Views (available on the website here) which was a shorter version of...

Logo
339 Views
Share
08 Oct 2015 18:02

Many (un)happy returns in EM; governance and the vicious circle

This report examines the underlying governance factors that have driven EM underperformance over the last five years.Brazil, Russia, Malaysia and...

Share
07 Oct 2015 03:15

Morningstar Healthcare Observer: Biotech Industry Undervalued

The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...

Share
06 Oct 2015 03:03

SoulCycle IPO - Good for your portfolio and your soul?

"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that...

Logo
312 Views
Share
29 Sep 2015 02:12

U.S. Economy Picks up the Pace: We're bumping up our 2015 GDP forecast

Growth in the second quarter was revised up from 3.7% to 3.9%, beating the consensus estimate of 3.7% growth.It was what economists like to call a...

Share
x